vs
Anteris Technologies Global Corp.（AVR）与Envoy Medical, Inc.（COCH）财务数据对比。点击上方公司名可切换其他公司
Anteris Technologies Global Corp.的季度营收约是Envoy Medical, Inc.的4.1倍（$310.0K vs $75.0K）。Envoy Medical, Inc.净利率更高（-8781.3% vs -9420.0%，领先638.7%）。Envoy Medical, Inc.自由现金流更多（$-5.9M vs $-18.9M）
Anteris Technologies Global Corp是一家专注于结构性心脏病诊疗解决方案的医疗科技企业，开发及商业化生物假体心脏瓣膜、经导管介入产品，服务北美、欧洲及亚太地区的医疗机构，核心业务覆盖心脏外科与介入心脏病学领域。
Envoy Medical是一家专注于植入式听力解决方案研发和商业化的医疗科技企业，核心产品为全植入式中耳听力设备，主要服务于使用常规外置助听器效果不佳的感音神经性听力损失患者，市场覆盖北美、欧洲等地区。
AVR vs COCH — 直观对比
营收规模更大
AVR
是对方的4.1倍
$75.0K
净利率更高
COCH
高出638.7%
-9420.0%
自由现金流更多
COCH
多$13.1M
$-18.9M
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $310.0K | $75.0K |
| 净利润 | $-29.2M | $-6.6M |
| 毛利率 | 70.6% | -181.3% |
| 营业利润率 | -9343.5% | -8513.3% |
| 净利率 | -9420.0% | -8781.3% |
| 营收同比 | — | 78.6% |
| 净利润同比 | — | -42.6% |
| 每股收益（稀释后） | $-0.74 | $-0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVRCOCH
| Q4 25 | $310.0K | $75.0K | ||
| Q3 25 | $429.0K | $42.0K | ||
| Q2 25 | $618.0K | $78.0K | ||
| Q1 25 | $556.0K | $46.0K | ||
| Q4 24 | — | $42.0K | ||
| Q3 24 | — | $56.0K | ||
| Q2 24 | — | $68.0K | ||
| Q1 24 | — | $59.0K |
净利润AVRCOCH
| Q4 25 | $-29.2M | $-6.6M | ||
| Q3 25 | $-22.2M | $-6.5M | ||
| Q2 25 | $-20.8M | $-5.7M | ||
| Q1 25 | $-21.9M | $-5.0M | ||
| Q4 24 | — | $-4.6M | ||
| Q3 24 | — | $-6.0M | ||
| Q2 24 | — | $-3.9M | ||
| Q1 24 | — | $-6.3M |
毛利率AVRCOCH
| Q4 25 | 70.6% | -181.3% | ||
| Q3 25 | 71.3% | -383.3% | ||
| Q2 25 | 76.1% | -200.0% | ||
| Q1 25 | 62.8% | -391.3% | ||
| Q4 24 | — | -273.8% | ||
| Q3 24 | — | -233.9% | ||
| Q2 24 | — | -260.3% | ||
| Q1 24 | — | -159.3% |
营业利润率AVRCOCH
| Q4 25 | -9343.5% | -8513.3% | ||
| Q3 25 | -5190.0% | -13590.5% | ||
| Q2 25 | -3379.3% | -6500.0% | ||
| Q1 25 | -3917.3% | -11102.2% | ||
| Q4 24 | — | -10828.6% | ||
| Q3 24 | — | -8878.6% | ||
| Q2 24 | — | -7135.3% | ||
| Q1 24 | — | -8278.0% |
净利率AVRCOCH
| Q4 25 | -9420.0% | -8781.3% | ||
| Q3 25 | -5185.1% | -15433.3% | ||
| Q2 25 | -3371.2% | -7294.9% | ||
| Q1 25 | -3932.4% | -10865.2% | ||
| Q4 24 | — | -10995.2% | ||
| Q3 24 | — | -10642.9% | ||
| Q2 24 | — | -5804.4% | ||
| Q1 24 | — | -10627.1% |
每股收益（稀释后）AVRCOCH
| Q4 25 | $-0.74 | $-0.27 | ||
| Q3 25 | $-0.62 | $-0.35 | ||
| Q2 25 | $-0.58 | $-0.32 | ||
| Q1 25 | $-0.61 | $-0.29 | ||
| Q4 24 | — | $-0.40 | ||
| Q3 24 | — | $-0.39 | ||
| Q2 24 | — | $-0.29 | ||
| Q1 24 | — | $-0.41 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | $22.0K | — |
| 股东权益账面价值 | $-93.0K | $-12.2M |
| 总资产 | $23.0M | $8.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AVRCOCH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $49.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
总债务AVRCOCH
| Q4 25 | $22.0K | — | ||
| Q3 25 | $26.0K | — | ||
| Q2 25 | $30.0K | — | ||
| Q1 25 | $30.0K | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AVRCOCH
| Q4 25 | $-93.0K | $-12.2M | ||
| Q3 25 | $3.7M | $-7.7M | ||
| Q2 25 | $24.4M | $-29.9M | ||
| Q1 25 | $43.3M | $-24.2M | ||
| Q4 24 | — | $-18.8M | ||
| Q3 24 | — | $-18.5M | ||
| Q2 24 | — | $-12.4M | ||
| Q1 24 | — | $-7.4M |
总资产AVRCOCH
| Q4 25 | $23.0M | $8.6M | ||
| Q3 25 | $19.1M | $8.2M | ||
| Q2 25 | $39.9M | $9.9M | ||
| Q1 25 | $58.8M | $10.4M | ||
| Q4 24 | — | $11.5M | ||
| Q3 24 | — | $9.4M | ||
| Q2 24 | — | $6.7M | ||
| Q1 24 | — | $8.5M |
负债/权益比AVRCOCH
| Q4 25 | — | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-18.5M | $-5.7M |
| 自由现金流经营现金流 - 资本支出 | $-18.9M | $-5.9M |
| 自由现金流率自由现金流/营收 | -6104.5% | -7809.3% |
| 资本支出强度资本支出/营收 | 128.1% | 229.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-79.8M | — |
8季度趋势，按日历期对齐
经营现金流AVRCOCH
| Q4 25 | $-18.5M | $-5.7M | ||
| Q3 25 | $-18.3M | $-4.3M | ||
| Q2 25 | $-19.5M | $-4.5M | ||
| Q1 25 | $-21.5M | $-3.7M | ||
| Q4 24 | — | $-5.1M | ||
| Q3 24 | — | $-2.6M | ||
| Q2 24 | — | $-4.6M | ||
| Q1 24 | — | $-5.6M |
自由现金流AVRCOCH
| Q4 25 | $-18.9M | $-5.9M | ||
| Q3 25 | $-19.0M | — | ||
| Q2 25 | $-20.1M | $-4.5M | ||
| Q1 25 | $-21.7M | $-3.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-3.8M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-5.7M |
自由现金流率AVRCOCH
| Q4 25 | -6104.5% | -7809.3% | ||
| Q3 25 | -4434.5% | — | ||
| Q2 25 | -3247.9% | -5719.2% | ||
| Q1 25 | -3909.5% | -8110.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -6750.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -9657.6% |
资本支出强度AVRCOCH
| Q4 25 | 128.1% | 229.3% | ||
| Q3 25 | 180.0% | 0.0% | ||
| Q2 25 | 86.9% | 1.3% | ||
| Q1 25 | 44.6% | 13.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2066.1% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 184.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
